Talc and Ovarian Cancer; Post hoc ergo propter hoc
Two weeks ago, May 20th the Baltimore Post Examiner and other papers around the country reported that Johnson & Johnson will
Read more
Matthew P. Boente MD FACS, FACOG a retired gynecologic oncologist after 30+ years of clinical care and both basic science and clinical research. I was formerly the Chief of Gynecologic Oncology at the Fox Chase Cancer Center in Philadelphia and later the same position at the University of MN. Finally, I retired after working at Genentech Inc., South San Francisco as the Medical director for Gynecologic Oncology Research in 2018, after reaching my task and Avastin was FDA approved for front line ovarian cancer. His brother Dana Boente is the former acting US Attorney General and now General counsel at the FBI.